AT
Anika Therapeutics Inc
🇩🇪XFRA.AKPGermanyHealthcare
€17.40EURdown -0.30 (-1.69%)OpenEnd of day6:48 AM
Price€17.40-0.30 (-1.69%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US0352551081
- CUSIP
- Not reported
Company
- Employees
- 235
- Headquarters
- Bedford, United States
- Website
- https://www.anika.com
- CEO
- Mr. Stephen D. Griffin
Market
- Shares outstanding
- 14.4M
- Market cap
- €250.93M
Highlights
No high and low reported for today's session.
- Market cap
- €250.93M
- EPS LTM
- -$0.28
- P/E LTM
- -51.92
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $120.65M+31.36%up year on year
- Net income
- -$3.78M+93.76%up year on year
- Gross margin
- 62.16%+7.63%up year on year
- Free cash flow
- $562K+149.52%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.